- Home
- CIGL vs BDSX Comparison
CIGL vs BDSX Comparison
Compare CIGL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGL
- BDSX
- Stock Information
- Founded
- CIGL 1997
- BDSX 2005
- Country
- CIGL Singapore
- BDSX United States
- Employees
- CIGL N/A
- BDSX N/A
- Industry
- CIGL Diversified Commercial Services
- BDSX Precision Instruments
- Sector
- CIGL Consumer Discretionary
- BDSX Health Care
- Exchange
- CIGL Nasdaq
- BDSX Nasdaq
- Market Cap
- CIGL 57.6M
- BDSX 53.0M
- IPO Year
- CIGL 2025
- BDSX 2020
- Fundamental
- Price
- CIGL $2.54
- BDSX $8.60
- Analyst Decision
- CIGL
- BDSX Strong Buy
- Analyst Count
- CIGL 0
- BDSX 5
- Target Price
- CIGL N/A
- BDSX $32.50
- AVG Volume (30 Days)
- CIGL 33.2K
- BDSX 305.4K
- Earning Date
- CIGL 09-29-2025
- BDSX 11-03-2025
- Dividend Yield
- CIGL N/A
- BDSX N/A
- EPS Growth
- CIGL N/A
- BDSX N/A
- EPS
- CIGL N/A
- BDSX N/A
- Revenue
- CIGL $11,072,733.00
- BDSX $80,173,000.00
- Revenue This Year
- CIGL N/A
- BDSX $19.04
- Revenue Next Year
- CIGL N/A
- BDSX $26.39
- P/E Ratio
- CIGL N/A
- BDSX N/A
- Revenue Growth
- CIGL 6.32
- BDSX 22.29
- 52 Week Low
- CIGL $1.40
- BDSX $3.44
- 52 Week High
- CIGL $31.06
- BDSX $32.20
- Technical
- Relative Strength Index (RSI)
- CIGL N/A
- BDSX 68.09
- Support Level
- CIGL N/A
- BDSX $6.19
- Resistance Level
- CIGL N/A
- BDSX $7.00
- Average True Range (ATR)
- CIGL 0.00
- BDSX 0.81
- MACD
- CIGL 0.00
- BDSX 0.02
- Stochastic Oscillator
- CIGL 0.00
- BDSX 94.85
About CIGL Concorde International Group Ltd Class A Ordinary Shares
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.